Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

The Guardian Health Wednesday 03 June 2026, 23:01 UTC By Anna Bawden Health and social affairs correspondent 1 min read

Key Points

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 yearsHundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant ovarian cancer to be approved for more than 20 years. Ovarian is the 18th most common type of cancer globally, affecting more than 300,000 women a year.

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years

Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant ovarian cancer to be approved for more than 20 years.

Ovarian is the 18th most common type of cancer globally, affecting more than 300,000 women a year. More than three-quarters of patients are diagnosed at an advanced stage, making it harder to treat.

England Elahere (LOCATION) NHS (ORG) NHS England (ORG)

Originally published by The Guardian Health Read original →

INDIANAPOLIS -- Colts wide receiver Alec Pierce, fresh off his four-year $114 million contract extension, still faces many weeks of recovery from left ankle surgery he underwent in March, he said Wednesday. The return timeline, which Pierce said can range from four to six months, could keep him out well into training camp and past the preseason. Pierce tried to avoid surgery, but consistent soreness in his ankle last season strongly suggested the issue needed to be addressed, he said.

ESPN 38m ago

Americans born after 1970 face higher death rates from several major causes in middle age

Americans born after 1970 are dying faster than their parents did, data shows. New analysis from Tufts University reveals that Gen Xers and millennials are failing to outlive their predecessors, dying at higher rates from common chronic illnesses and external causes than previous generations did when they were the same age. Data shows that U.S. life expectancy has steadily improved for most of the 20th century, meaning each generation generally lived longer than the one before it.

Fox News 51m ago

First ever guidelines released to screen for condition that impacts 9 in 10 Americans

First ever guidelines released to screen for condition that impacts 9 in 10 Americans Doctors say earlier screening could help save lives - Bookmark - CommentsGo to comments Some 90 percent of Americans have at least one risk factor for cardiovascular-kidney-metabolic – or CKM – syndrome, a term for potentially life-threatening conditions that are all connected. Now, experts at the American Heart Association say more of the country should be screened for one particular risk factor in the...

The Independent World 52m ago

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

Related Stories

What happens when a gas company abandons an entire city?

Colts' Pierce could be out well into training camp...

Americans born after 1970 face higher death rates from several major causes in middle age

First ever guidelines released to screen for condition that impacts 9 in 10 Americans